8-K: Leidos Holdings Reports Strong Second Quarter Results, Driven by Growth in Health Services

Leidos Holdings, Inc. announced an 8% year-over-year revenue increase to $4.1 billion and a 54% increase in net income to $324 million for the second quarter of fiscal year 2024.

Summary

• Leidos reported revenues of $4.1 billion for the second quarter of fiscal year 2024, an 8% increase compared to the same period last year.
• Net income for the quarter was $324 million, or $2.37 per diluted share, representing a 54% increase year-over-year.
• Adjusted EBITDA reached $559 million, a 33% increase year-over-year, with a record margin of 13.5%.
• Non-GAAP diluted earnings per share were $2.63, up 46% year-over-year.
• The company generated $374 million in cash from operations and $351 million in free cash flow.
• Net bookings for the quarter totaled $4.0 billion, resulting in a book-to-bill ratio of 1.0.
• Leidos' backlog stands at $36.5 billion, with $8.0 billion funded.
• The company returned $165 million to shareholders through share repurchases and dividends.
• Leidos is updating its fiscal year 2024 revenue guidance to $16.1 $16.4 billion, with an adjusted EBITDA margin of approximately 12% and non-GAAP diluted EPS of $8.60 $9.00.

Sentiment

Score: 9

Explanation: The document conveys a very positive sentiment due to strong financial results, increased guidance, and positive management commentary. The company's performance exceeded expectations, and there are no significant negative issues highlighted.

Positives

• Leidos experienced strong revenue growth across all customer segments, particularly in managed health services.
• The company's profitability improved significantly, driven by increased volumes, higher earned incentives, and improved cost control.
• Leidos demonstrated strong cash generation, with $374 million in operating cash flow and $351 million in free cash flow.
• The company's book-to-bill ratio of 1.0 indicates a healthy pipeline of future work.
• Leidos is increasing its full-year guidance for adjusted EBITDA margin and non-GAAP diluted EPS.
• The company's Days Sales Outstanding (DSO) improved by one day to 58 days.

Negatives

• The Commercial & International segment experienced a decrease in operating income margin due to contract adjustments in the UK business.
• The company has $4.7 billion of debt as of June 28, 2024.

Risks

• The company's performance is subject to developments in U.S. government defense and non-defense budgets, including potential budget reductions and delays.
• Uncertainties in tax due to new tax legislation or other regulatory developments could impact financial results.
• Rising inflationary pressures and fluctuations in interest rates may affect costs and profitability.
• Delays in the U.S. government contract procurement process or the award of contracts could impact revenue.
• The company faces risks related to cybersecurity, data security, and other security threats.
• The company's ability to attract, train, and retain skilled employees is crucial for its success.
• The company's ability to accurately estimate costs associated with firm-fixed-price contracts is important for profitability.

Future Outlook

Leidos is updating its fiscal year 2024 guidance, projecting revenues between $16.1 and $16.4 billion, an adjusted EBITDA margin of approximately 12%, and non-GAAP diluted EPS between $8.60 and $9.00. Cash flows provided by operating activities are expected to be approximately $1.3 billion.

Management Comments

• Thomas Bell, Leidos Chief Executive Officer, stated that Leidos continued its industry-leading profitable growth and strong cash generation in the second quarter.
• He also highlighted the company's progress towards key operational priorities and its dedication to the 'Promises Made, Promises Kept' philosophy.
• Bell noted that the company's collaborative innovation strategy and capabilities-based organization position it well to deliver on its commitments for the remainder of 2024 and beyond.

Industry Context

Leidos' strong performance reflects the continued demand for technology and services in the national security and health sectors. The company's focus on innovation and its ability to secure large government contracts positions it well within the competitive landscape. The growth in managed health services aligns with broader trends in healthcare outsourcing and digital transformation.

Comparison to Industry Standards

• Leidos' 8% revenue growth is strong compared to some of its peers in the government contracting sector, such as General Dynamics (GD) and Northrop Grumman (NOC), which have seen more modest growth in recent quarters.
• The 33% increase in adjusted EBITDA and 13.5% margin are particularly impressive, suggesting strong operational efficiency and cost management compared to companies like Booz Allen Hamilton (BAH) and CACI International (CACI).
• The book-to-bill ratio of 1.0 indicates a stable pipeline of future work, which is comparable to industry standards for companies with large government contracts.
• The company's focus on managed health services is a differentiator, as many competitors are more heavily focused on defense and national security contracts.

Stakeholder Impact

• Shareholders will benefit from the strong financial results, increased guidance, and return of capital through share repurchases and dividends.
• Employees may benefit from the company's growth and success.
• Customers will benefit from the company's continued focus on innovation and delivery of high-quality services.
• Suppliers and creditors will benefit from the company's strong financial position.

Next Steps

• Leidos management will discuss operations and financial results in an earnings conference call on July 30, 2024.
• The company will continue to execute on its business plan and long-term management initiatives.
• Leidos will focus on delivering on its commitments for the remainder of 2024 and beyond.

Key Dates

Keywords

Leidos, Financial Results, Second Quarter, Revenue Growth, EBITDA, Net Income, Bookings, Backlog, Defense, Health, Technology, Government Contracts